Prosecution Insights
Last updated: May 29, 2026
Application No. 18/141,847

ADHESIVE COMPOSITION

Final Rejection §103
Filed
May 01, 2023
Priority
Apr 29, 2022 — provisional 63/336,508
Examiner
JOHNSTON, BRIEANN R
Art Unit
1766
Tech Center
1700 — Chemical & Materials Engineering
Assignee
Quin Global US Inc.
OA Round
2 (Final)
49%
Grant Probability
Moderate
3-4
OA Rounds
0m
Est. Remaining
82%
With Interview

Examiner Intelligence

Grants 49% of resolved cases
49%
Career Allowance Rate
493 granted / 1008 resolved
-16.1% vs TC avg
Strong +33% interview lift
Without
With
+32.9%
Interview Lift
resolved cases with interview
Typical timeline
2y 10m
Avg Prosecution
50 currently pending
Career history
1067
Total Applications
across all art units

Statute-Specific Performance

§103
88.2%
+48.2% vs TC avg
§102
9.6%
-30.4% vs TC avg
§112
1.2%
-38.8% vs TC avg
Black line = Tech Center average estimate • Based on career data from 1008 resolved cases

Office Action

§103
DETAILED ACTION This office action follows a reply filed on May 4, 2026. Claims 1, 8-9 and 15-16 have been amended. Claims 1, 6-9 and 13-16 are currently pending and under examination. The texts of those sections of Title 35 U.S. Code are not included in this section and can be found in a prior Office action. Claim Objections Claims 8 and 15 are objected to because of the following informalities: In claims 8 and 15, the word “silicon” should be “silicone”. Appropriate correction is required. Claim Rejections - 35 USC § 103 Claims 1, 6-9 and 13-16 are rejected under 35 U.S.C. 103 as being unpatentable over Damke (US 2019/0300712). Damke teaches adhesive materials comprising the following: a) at least one polymer having at least one terminal group of the general formula -Zn-R-SiXYZ, and meets applicants’ silylated polymer, exemplified as a polyether-based gamma silane terminated polymer which is terminated with a trimethoxysilane (p. 8, [0098]); b) at least one compound of the general formula PNG media_image1.png 90 260 media_image1.png Greyscale , which meets applicants’ silicone resin intermediate; and an adhesion promoter, which includes rosins and derivatives thereof (p. 6, [0078]), where gum rosin is synonymous with rosin. Damke does not teach or suggest the peel strength, as claimed; however, Damke does teach that when X, Y and Z are methoxy groups, rapid curing is possible which is desirable for adhesives with which high initial adhesion is required (p. 4, [0059]). Damke also teaches that the rosin adhesion promoter improves the adhesion properties of adhesive layers on surfaces (p. 6, [0078]). Polymer (a) is present in an amount of preferably 20-60 wt% (p. 5, [0062]) and compound (b) is present in an amount of preferably 2-50 wt% (p. 5, [0066]) and the tackifier adhesion promoter is taught as being present in an amount of 0.1-5 wt% (p. 6, [0081]). When the adhesion promoter is present in an amount of 5 wt%, and the resin components are present in an amount of 94 wt%, the ratio of tackifier to resin is 0.05. Additionally, the inclusion of other additives, such as plasticizers, catalyst, drying agent, solvent, etc., a ratio of 5/65 or about 0.08 is possible. Therefore, it can be seen that the suggested compositions of Damke possess a weight ratio of tackifying resin to polymer which overlaps with the claimed range of 0.05-2.5, and it has been held that overlapping ranges are sufficient to establish prima facie obviousness. See MPEP 2144.05. Therefore, it would have been obvious to one of ordinary skill in the art at the time the invention was made to have selected from the overlapping portion of the range taught by the reference because overlapping ranges have been held to establish prima facie obviousness. The components described by Damke are the same as those claimed, and are taught in amounts which are suggested by the instant invention; therefore, one of ordinary skill in the art would expect the adhesives of Damke as having similar peel strength properties as those claimed. Damke is prima facie obvious over instant claims 1-3, 5 and 8. As to claims 6-7, Damke teaches that the adhesion promoters can include coumarone/indene resins and terpene phenolic resins, teaching that they can be use individually or as a combination of several compounds. Choosing a combination of rosin and coumarone/indene resins and/or terpene phenolic resin is prima facie obvious. As to claim 9, Damke teaches the inclusion of a solvent to reduce the viscosity, which includes ketones and esters (p. 6, [0076]), where acetone is known as the simplest ketone, and methyl acetate is known as the simplest ester solvent, and are both very well-known solvents. The remaining limitations can be met as described above. Claims 13-16 can be rejected as described above. Claims 1 and 7-8 are rejected under 35 U.S.C. 103 as being unpatentable over Garnier (US 2022/0049143). Garnier teaches adhesive compositions comprising the following: (A) at least one polymer comprising a hydrolysable alkoxysilane group, which meets applicants’ silyl terminated polymer; (B) at least one tackifying resin, which includes (i) terpene phenols and (iii) rosins of natural origin for instance that extracted from pine gum, suggesting a combination of such can be used; (C) at least one silsesquioxane, which meets applicants’ silicone intermediate; and (D) at least one crosslinking catalyst. Garnier exemplifies a ratio of tackifying resin to polymer of about 0.05-0.1 in Examples 1-2, showing that when some of the tackifying resin is substituted with the silsesquioxane, the peel strength significantly increases. Garnier teaches that the adhesive has high peel strength on stainless steel and polymer but does not teach the peel strength as measured by the instant invention; however, the compositions of Garnier suggest the claimed adhesives using applicants claimed components in similar amounts as described in the instant disclosure. Therefore, one of ordinary skill in the art would expect the adhesives of Garnier to possess a similar peel strength, as claimed. Garnier is prima facie obvious over instant claims 1 and 7-8. Response to Arguments Applicant's arguments filed May 4, 2026 have been fully considered but they are not persuasive. Applicant's arguments fail to comply with 37 CFR 1.111(b) because they amount to a general allegation that the claims define a patentable invention without specifically pointing out how the language of the claims patentably distinguishes them from the references. Conclusion THIS ACTION IS MADE FINAL. Applicant is reminded of the extension of time policy as set forth in 37 CFR 1.136(a). A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any nonprovisional extension fee (37 CFR 1.17(a)) pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the mailing date of this final action. Any inquiry concerning this communication or earlier communications from the examiner should be directed to BRIEANN R JOHNSTON whose telephone number is (571)270-7344. The examiner can normally be reached Monday-Friday, 8:00 AM - 4:00 PM EST. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Randy Gulakowski can be reached at (571)272-1302. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /Brieann R Johnston/Primary Examiner, Art Unit 1766
Read full office action

Prosecution Timeline

May 01, 2023
Application Filed
Dec 04, 2025
Non-Final Rejection mailed — §103
May 04, 2026
Response Filed
May 19, 2026
Final Rejection mailed — §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12630706
MEMBRANE COMPRISING A BLEND OF POLYARYLETHERSULFONE AND POLYARYLETHERKETONE AND METHOD FOR MANUFACTURING THEREOF
4y 4m to grant Granted May 19, 2026
Patent 12624176
RESIN COMPOSITION, PREPREG, FILM WITH RESIN, METAL FOIL WITH RESIN, METAL-CLAD LAMINATE, AND WIRING BOARD
4y 4m to grant Granted May 12, 2026
Patent 12612530
HYDROPHOBIC FLUID AND USE THEREOF
4y 4m to grant Granted Apr 28, 2026
Patent 12599545
DENTAL ADHESIVE COMPOSITION, DENTAL ADHESIVE MATERIAL, AND DENTAL ADHESIVE MATERIAL PACKAGE
3y 10m to grant Granted Apr 14, 2026
Patent 12595385
INKJET INKS
3y 9m to grant Granted Apr 07, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

3-4
Expected OA Rounds
49%
Grant Probability
82%
With Interview (+32.9%)
2y 10m (~0m remaining)
Median Time to Grant
Moderate
PTA Risk
Based on 1008 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month